This stamp of approval designates that NextGen Ambulatory EHR 5.9 is 2015 Edition certified electronic health record technology (CEHRT) and offers the functionality for eligible providers and hospitals to meet MIPS ACI and Meaningful Use Stage 3 requirements, qualifying these organizations to receive payments under the ongoing Quality Payment Program (QPP) and Meaningful Use (MU) EHR Incentive Programs.
"Achieving 2015 Edition certification of our NextGen Ambulatory EHR 5.9
is all about supporting our clients," said
2015 Edition Disclosure Language
This Health IT Module - NextGen Ambulatory EHR 5.9 - is 2015 Edition
compliant and has been certified by an ONC-ACB in accordance with the
applicable certification criteria adopted by the Secretary of
NextGen Ambulatory EHR 5.9 was created by
SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS
This news release may contain forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements made by Rusty Frantz, President and CEO, statements regarding certifications of the Company's products, and other statements regarding future events, developments in the Company's business and in the overall healthcare sector, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future. The Company cautions investors not to place undue reliance on any such forward-looking statements, which are based on information available at the time those statements are made or management's good faith belief as of that time with regard to future events, and should not be read as a guarantee of future performance or results. Risks and uncertainties exist that may cause the results to differ materially from those set forth in these forward-looking statements. Factors that could cause the anticipated results to differ from those described in the forward-looking statements and additional risks and uncertainties are set forth in Part I, Item A of our most recent Annual Report on Form 10-K and subsequently filed Quarterly Reports on Form 10-Q, including but not limited to: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; litigation and government investigations; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; disruptions caused by acquisitions of companies, products, or technologies; and general economic conditions. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
For Investor Relations Inquiries:
Chief Financial Officer
For Media and Public Relations Inquiries:
News Provided by Acquire Media